Skip to main content

Advertisement

Log in

Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A new study has proposed a mechanism for the pathogenesis of cerebral cavernous malformation (CCM) that links endothelial CCM3 deficiency to increased secretion of the vascular destabilizing protein angiopoietin-2 (ANGPT2).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The pathogenesis of CCM3-associated cerebral cavernous malformation.

Marina Corral Spence/Nature Publishing Group

References

  1. Clatterbuck, R.E., Eberhart, C.G., Crain, B.J. & Rigamonti, D. J. Neurol. Neurosurg. Psychiatry 71, 188–192 (2001).

    Article  CAS  Google Scholar 

  2. Plummer, N.W., Zawistowski, J.S. & Marchuk, D.A. Curr. Neurol. Neurosci. Rep. 5, 391–396 (2005).

    Article  CAS  Google Scholar 

  3. Draheim, K.M., Fisher, O.S., Boggon, T.J. & Calderwood, D.A. J. Cell Sci. 127, 701–707 (2014).

    Article  CAS  Google Scholar 

  4. Chan, A.C. et al. J. Clin. Invest. 121, 1871–1881 (2011).

  5. Whitehead, K.J. et al. Nat. Med. 15, 177–184 (2009).

  6. Zhou, Z. et al. Nature 532, 122–126 (2016).

    Article  CAS  Google Scholar 

  7. Maddaluno, L. et al. Nature 498, 492–496 (2013).

    Article  CAS  Google Scholar 

  8. Zhou, H.J. et al. Nat. Med. 22, 1033–1042 (2016).

    Article  CAS  Google Scholar 

  9. Fiedler, U. et al. Blood 103, 4150–4156 (2004).

    Article  CAS  Google Scholar 

  10. Gibson, C.C. et al. Circulation 131, 289–299 (2015).

    Article  CAS  Google Scholar 

  11. Hapani, S., Chu, D. & Wu, S. Lancet Oncol. 10, 559–568 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dean Y Li.

Ethics declarations

Competing interests

D.Y.L. is cofounder of the biotechnology companies Navigen and Recursion Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, H., Mleynek, T. & Li, D. Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation. Nat Med 22, 971–973 (2016). https://doi.org/10.1038/nm.4178

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4178

  • Springer Nature America, Inc.

Navigation